Titre : bêta-Alanine

bêta-Alanine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Dialectical Behavior Therapy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "bêta-Alanine : Questions médicales les plus fréquentes", "headline": "bêta-Alanine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les bêta-Alanine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-16", "dateModified": "2025-03-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "bêta-Alanine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Alanine", "url": "https://questionsmedicales.fr/mesh/D000409", "about": { "@type": "MedicalCondition", "name": "Alanine", "code": { "@type": "MedicalCode", "code": "D000409", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acide pantothénique", "alternateName": "Pantothenic Acid", "url": "https://questionsmedicales.fr/mesh/D010205", "about": { "@type": "MedicalCondition", "name": "Acide pantothénique", "code": { "@type": "MedicalCode", "code": "D010205", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.042.070.500" } } } ], "about": { "@type": "MedicalCondition", "name": "bêta-Alanine", "alternateName": "beta-Alanine", "code": { "@type": "MedicalCode", "code": "D015091", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Bryan Saunders", "url": "https://questionsmedicales.fr/author/Bryan%20Saunders", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Eimear Dolan", "url": "https://questionsmedicales.fr/author/Eimear%20Dolan", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, Rheumatology Division, Faculdade de Medicina FMUSP, School of Physical Education and Sport, University of São Paulo, São Paulo, Brazil." } }, { "@type": "Person", "name": "Bruno Gualano", "url": "https://questionsmedicales.fr/author/Bruno%20Gualano", "affiliation": { "@type": "Organization", "name": "Applied Physiology and Nutrition Research Group, School of Physical Education and Sport; Rheumatology Division; Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, SP, BR, University of São Paulo, Brazil." } }, { "@type": "Person", "name": "Marcelo Papoti", "url": "https://questionsmedicales.fr/author/Marcelo%20Papoti", "affiliation": { "@type": "Organization", "name": "University of São Paulo, Medicine University of Ribeirão Preto (FMRP-USP), Ribeirão Preto, São Paulo, Brazil." } }, { "@type": "Person", "name": "Craig Sale", "url": "https://questionsmedicales.fr/author/Craig%20Sale", "affiliation": { "@type": "Organization", "name": "Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement Research Centre, Nottingham Trent University, United Kingdom." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Investigating predictors of treatment response in Dialectical Behavior Therapy for borderline personality disorder using LASSO regression.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36305345", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/10503307.2022.2138790" } }, { "@type": "ScholarlyArticle", "name": "Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis.", "datePublished": "2024-05-22", "url": "https://questionsmedicales.fr/article/38776336", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0303967" } }, { "@type": "ScholarlyArticle", "name": "Treatment outcomes of Veteran men in a comprehensive dialectical behavior therapy program: Characterizing sex differences in symptom trajectories.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37331262", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpsychires.2023.05.065" } }, { "@type": "ScholarlyArticle", "name": "Group brief cognitive behavioral therapy for suicide prevention compared to dialectal behavior therapy skills group for military service members: a study protocol of a randomized controlled trial.", "datePublished": "2023-12-05", "url": "https://questionsmedicales.fr/article/38053122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12888-023-05282-x" } }, { "@type": "ScholarlyArticle", "name": "Experiences of dialectical behaviour therapy for adolescents: A qualitative analysis.", "datePublished": "2023-02-09", "url": "https://questionsmedicales.fr/article/36756991", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/papt.12447" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Alanine", "item": "https://questionsmedicales.fr/mesh/D000409" }, { "@type": "ListItem", "position": 5, "name": "bêta-Alanine", "item": "https://questionsmedicales.fr/mesh/D015091" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : bêta-Alanine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur bêta-Alanine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur bêta-Alanine", "description": "Comment diagnostiquer une carence en bêta-alanine ?\nQuels tests peuvent évaluer les niveaux de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur bêta-Alanine", "description": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?\nLa bêta-alanine cause-t-elle des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur bêta-Alanine", "description": "Comment prévenir une carence en bêta-alanine ?\nLes sportifs doivent-ils se supplémenter en bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur bêta-Alanine", "description": "La bêta-alanine est-elle utilisée pour traiter des maladies ?\nComment la bêta-alanine améliore-t-elle la performance ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur bêta-Alanine", "description": "Quelles complications peuvent survenir avec une surconsommation ?\nLa bêta-alanine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur bêta-Alanine", "description": "Qui est à risque de carence en bêta-alanine ?\nLes athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "url": "https://questionsmedicales.fr/mesh/D015091?mesh_terms=Dialectical+Behavior+Therapy&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en bêta-alanine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de test spécifique; une évaluation des symptômes et des apports alimentaires est nécessaire." } }, { "@type": "Question", "name": "Quels tests peuvent évaluer les niveaux de bêta-alanine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines peuvent mesurer les niveaux d'acides aminés, y compris la bêta-alanine." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une supplémentation excessive en bêta-alanine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une supplémentation excessive peut provoquer des picotements, des démangeaisons ou des rougeurs." } }, { "@type": "Question", "name": "La bêta-alanine cause-t-elle des effets secondaires ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des effets secondaires comme des picotements peuvent survenir, mais ils sont généralement bénins." } }, { "@type": "Question", "name": "Comment prévenir une carence en bêta-alanine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée incluant des sources de protéines peut prévenir une carence." } }, { "@type": "Question", "name": "Les sportifs doivent-ils se supplémenter en bêta-alanine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les sportifs peuvent bénéficier d'une supplémentation pour améliorer leur endurance et performance." } }, { "@type": "Question", "name": "La bêta-alanine est-elle utilisée pour traiter des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle n'est pas un traitement médical, mais un complément pour améliorer la performance sportive." } }, { "@type": "Question", "name": "Comment la bêta-alanine améliore-t-elle la performance ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle augmente les niveaux de carnosine dans les muscles, retardant la fatigue lors d'exercices intenses." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une surconsommation ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles gastro-intestinaux et des picotements." } }, { "@type": "Question", "name": "La bêta-alanine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions sont possibles; il est conseillé de consulter un professionnel de santé." } }, { "@type": "Question", "name": "Qui est à risque de carence en bêta-alanine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant une alimentation pauvre en protéines ou végétalienne peuvent être à risque." } }, { "@type": "Question", "name": "Les athlètes d'endurance ont-ils besoin de plus de bêta-alanine ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir besoin de plus de bêta-alanine pour améliorer leur performance et récupération." } } ] } ] }

Sources (10000 au total)

Investigating predictors of treatment response in Dialectical Behavior Therapy for borderline personality disorder using LASSO regression.

Prior studies of Dialectical Behavior Therapy (DBT) for borderline personality disorder (BPD) have yielded heterogeneous findings on what factors differentiate individuals with or without sufficient t... We investigated a sample of 105 individuals with BPD receiving a 6-month course of DBT. Participants were categorized as sufficient or insufficient responders using clinical and statistical change ind... Two cross-validated LASSO regression models predicted treatment response (AUCs > .75). They suggested that higher homework completion rate, retention in treatment, and greater baseline severity were t... Future research may benefit from consolidating the criteria of treatment response, identifying clinically relevant variables, and testing the generalizability of findings to enhance knowledge of insuf...

Dialectical Behavior Therapy as an intervention for Treatment Resistant Depression in adults: A protocol for systematic review and meta-analysis.

Major Depressive Disorder is a long-term, recurring, and very common illness that is associated with a significant decline in functional ability. The gold-standard method of treating depression is pha... We will search for publications in the following databases: Cochrane Central Register of Controlled Trials, MEDLINE, Embase, Lilacs, Web of Science, and PsycINFO. We will manually review the reference... Ethical approval was not required as individual patient data was not obtained. Our intention is to publish the systematic review in a medical journal that offers open access upon completion of the pro... PROSPERO registration number CRD42023406301. Registered on March 24, 2023....

Group brief cognitive behavioral therapy for suicide prevention compared to dialectal behavior therapy skills group for military service members: a study protocol of a randomized controlled trial.

Suicide is a pressing matter for the military. Not only does it pose a health risk, but suicide also compromises operational readiness. Despite provision of suicide prevention clinical best practices,... This 2-arm non-inferiority randomized controlled trial compares a group therapy format of Brief Cognitive Behavioral Therapy (i.e., G-BCBT) with Dialectical Behavior Therapy (DBT) Skills Group. Both t... The primary outcome concerns G-BCBT impacts on suicidal ideation. Secondary outcomes of interest are suicide attempt, psychological distress (e.g., symptoms of depression, anxiety), and self-regulator... This study was registered at Clinicaltrials.gov (protocol NCT05401838)....

Experiences of dialectical behaviour therapy for adolescents: A qualitative analysis.

To explore how former patients in dialectical behaviour therapy for adolescents (DBT-A) experience their treatment, and specifically if there were aspects of the treatment that they retrospectively id... From a larger sample of 75 former DBT-A patients 19 were selected for a qualitative semi-structured interview study.... Young adults (N = 19; 18 females, one male), who as adolescents had been enrolled in DBT-A due to self-harming behaviours and features of borderline personality disorder, were interviewed up to 8 year... Six key themes were revealed; (1) The need to be seen, listened to and believed in, (2) the importance of teamwork between patient and therapist, (3) the value of group and structure, (4) therapy as l... A trusting relationship with the therapist promoted commitment and motivation for treatment. This relationship was facilitated by the therapist showing explicit care and belief in the patient's own co...

The Effectiveness of 6 versus 12 Months of Dialectical Behavior Therapy for Borderline Personality Disorder: A Noninferiority Randomized Clinical Trial.

Evidence-based psychotherapies for borderline personality disorder (BPD) are lengthy, posing a barrier to their access. Brief psychotherapy may achieve comparable outcomes to long-term psychotherapy f... The aim was to determine if 6 months of Dialectical Behavior Therapy (DBT) is noninferior to 12 months of DBT in terms of clinical effectiveness.... This two-arm, single-blinded, randomized controlled noninferiority trial with suicidal or self-harming patients with BPD was conducted at two sites in Canada. Participants (N = 240, M (SD)age = 28.27 ... The noninferiority hypothesis was supported for the primary outcome, total self-harm (6 months: margin = -1.94, Mdiff [95% CI] = 0.16 [-0.14, 0.46]; 12 months: margin = -1.47, Mdiff [95% CI] = 0.04 [-... The noninferiority of a briefer yet comprehensive treatment for BPD has potential to reduce barriers to treatment access....

Using Biosensor Devices and Ecological Momentary Assessment to Measure Emotion Regulation Processes: Pilot Observational Study With Dialectical Behavior Therapy.

Novel technologies, such as ecological momentary assessment (EMA) and wearable biosensor wristwatches, are increasingly being used to assess outcomes and mechanisms of change in psychological treatmen... Our objectives were to assess the feasibility and acceptability of incorporating these technologies into dialectical behavior therapy and conduct a pilot evaluation of whether these technologies can b... A total of 20 adults with borderline personality disorder were enrolled in a 6-month course of dialectical behavior therapy. For 1 week out of every treatment month, participants were asked to complet... On average, participants completed 54.39% (SD 33.1%) of all EMA (range 4.7%-92.4%). They also wore the device for an average of 9.52 (SD 6.47) hours per day and for 92.6% of all days. Importantly, no ... Results indicated moderate overall compliance with EMA and wearing the watch; however, there was no concurrence between EMA and wristwatch data on emotions. This pilot study raises questions about the...

Adolescent experience of radically open dialectical behaviour therapy: a qualitative study.

Radically Open Dialectical Behaviour Therapy (RO DBT) is a novel transdiagnostic treatment that targets 'maladaptive overcontrol'; a transdiagnostic cluster of traits associated with excessive emotion... Of the 25 eligible adolescents who received RO DBT between March 2015 and April 2017, 15 (14-17 years) consented and completed a semi-structured interview about their experience of treatment within 1 ... The majority (n = 13) had a primary diagnosis of anorexia nervosa, although comorbidity was the norm, with 80.0% having two or more predicted comorbid psychiatric diagnoses. All had received some prio... RO DBT is perceived as a relevant and beneficial new treatment for adolescents with maladaptive overcontrol. The broad treatment focus is perceived as unique and of particular benefit. It is reported ...

Feasibility and Efficacy of Intensive Dialectical Behavior Therapy Skills Training in An Outpatient Setting for A Group of Patients with Extensive Care Needs - A Transdiagnostic Approach.

Dialectical behavior therapy (DBT) is a treatment originally developed för chronically suicidal adults. It is common to adapt it by using one specific component, the DBT skills training (DBT-ST) and a... Thirty-seven participants completed the Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM), and visual analogue scale (VAS) at three time points: pre-intervention, post-intervention a... One-way ANOVA showed a significant effect for time on the CORE-OM: F (2,35) = 7.93, p = .001, η... These study results confirm to some extent the feasibility and effectiveness of the intensive DBT-ST in a transdiagnostic clinical setting. The participants had a positive outcome from the skills trai...